Vous êtes ici

Curriculum Vitae

Expand | Collapse

Efthymia Vlachaki

Assistant Professor, School of Medicine

Personal Information

- 2310857111
efivlachaki@auth.gr
Επιστημονική Ειδίκευση: Ιατρική

Education

Προπτυχιακές Σπουδές

1988	Πτυχίο ΙΑΤΡΙΚΗ ΑΠΘ Greece ΑΙΜΑΤΟΛΟΓΙΑ

Διδακτορικό Δίπλωμα

2003	ΔΔ ΙΑΤΡΙΚΗ ΑΠΘ Greece ΑΙΜΑΤΟΛΟΓΙΑ

Course Work

Courses of Winter semester of 2017–18 academic year

	TMĪMA IATRIKĪS
ΙΑ0319	Internal Medicine
ΙΑ0321	Internal Medicine II
ΙΑ0402	Hematologic Manifastations in Systematic Diseases

	METAPTYCΗIAKO TMĪMATOS FARMAKEUTIKĪS
ΦΘ0003	PHYSIOLOGY-PATHOPHYSIOLOGY

Courses of Spring semester of 2017–18 academic year

	TMĪMA IATRIKĪS
IA0376	Medical Oncology
ΙΑ0289	Clinical Immunology
ΙΑ0319	Internal Medicine
ΙΑ0320	Internal Medicine I

Theses Supervised

Student Theses within AUTh

In progress

Apostolou Chrysoula. Η σημασία των πρώιμων δεικτών της νεφρικής σωληναριακής βλάβης στην έγκαιρη διάγνωση της σε ενήλικες ασθενείς με β-μεσογειακή αναιμία

Administrative Work

Άλλο
#	Από	Έως	Θέση Περιγραφή
2	2014	2015
1	2002	2003	Μέλος, Τμήμα Ερυθροκυττάρου και Αιμοσφαιρινοπαθειών της Ελληνικής Αιματολογικής Εταιρείας

Research Projects

2016–2016	Εκπαιδευτική ενημέρωση για τη νόσο Caucher
2015–2017	Μελέτη της μετάλλαξης JAK-2-V617F στα μυελουπερπλαστικά νοσήματα
2015–2015	Νεότερα δεδομένα στη θεραπευτική αντιμετώπιση ασθενών με β-θαλασσαιμία
2015–2017	Εκτίμηση της ηπατικής ίνωσης με τη βοήθεια της ελαστογραφίας σε ασθενείς με ομόζυγη β-μεσογειακή αναιμία οι οποίοι λαμβάνουν αποσιδήρωση επι 5 έτη με δεφερασιρόξη
2014–2021	Μια τυχαιοποιημένη, διπλά τυφλή, ελεγχόμενη με εικονικό φάρμακο, φάσης ΙΙΙ, πολυκεντρική μελέτη της θεραπείας με eltrombopag ή με εικονικό φάρμακο σε συνδυασμό με αζακιτιδίνη σε ασθενείς με μυελοδυσπλαστικά σύνδρομα (ΜΔΣ) ενδιάμεσου-2 και υψηλού κινδύνου κατά IPSS
2014–2015	Μελέτη πολυμορφισμών της συνθετάσης του ΝΟ σε ασθενείς με δρεπανοκυτταρική νόσο και πνευμονική υπέρταση.
2014–2015	ΔΡΑΣΗ Α: Ενίσχυση Νέων Ερευνητών στη βαθμίδα του Λέκτορα (β' φάση): Εκτίμηση της ηπατικής ίνωσης με τη βοήθεια της ελαστογραφίας σε ασθενείς με ομόζυγη β-μεσογειακή αναιμία οι οποίοι λαμβάνουν αποσιδήρωση επι 5 έτη με δεφερασιρόξη.
2014–2014	Ομιλία στα πλαίσια εκπαίδευσης στο προσωπικό εταιρίας Glaxo για το Revolade.
2014–2016	Μελέτη της μετάλλαξης JAK-2-V617F στα μυελουπερπλαστικά νοσήματα
2014–2014	Αποσιδήρωση στα Μυελοδυσπλαστικά Σύνδρομα - Εκπάιδευση προσωπικού Novartis.
2013–2014	Εκπαιδευτικό πρόγραμμα για τη θαλασσαιμία στο προσωπικό της Novartis.
2013–2013	Επιστημονική συνάντηση για τη β-Θαλασσαιμία
2013–2013	Ομιλία στην ημερίδα: "Εξελίξεις και προοπτικές στη θαλασσαιμία" με θέμα: Θνητότητα και νοσηρότητα στη θαλασσαιμία. Επιτεύξεις, προκλήσεις για το μέλλον

Connection to Society

Publications

2017

Mainou M, Madenidou AV, Liakos A, Paschos P, Karagiannis T, Bekiari Eleni, Vlachaki Efthymia, Wang Z, Murad MH, Kumar S, Tsapas Apostolos (2017). Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma: A systematic review and meta-regression analysis. European Journal of Haematology. vol.98 no.6 p.563-568.

2015

Sarigianni M, Liakos Aris, Vlachaki Efthymia, Paschos Paschalis, Athanasiadou E, Montori VM, Tsapas Apostolos (2015). Accuracy of Magnetic Resonance Imaging in Diagnosis of Liver Iron Overload: a Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. Vol.13 no.1 p.55-63.e5.

2014

Theodoridou S, Economou M, Vyzantiadis Timoleon-Achilleas, Teli A, Vlachaki Efthymia, Neokleous N, Kargioti A, Vakalopoulou Sofia, Garypidou-Vratskidou Vasileia, Gombakis N, Papachristou Fotios (2014). Laboratory investigation of platelet function in patients with thalassaemia. Acta Haematologica.
Vlachaki Efthymia, Agapidou Aleka, Neokleous Nikolaos, Adamidou Despoina, Vetsiou Evaggelia, Boura Panagiota (2014). Thrombotic thrombocytopenic purpura or immune thrombocytopenia in a sickle cell/β+-thalassemia patient: A rare and challenging condition. Transfusion and Apheresis Science. vol.51 no.2 p.175-177.

2013

Agapidou A, Vlachaki Efthymia, Theodoridis Theodoros, Economou M, Perifanis Vasileios (2013). Cyclosporine therapy during pregnancy in a patient with β-thalassemia major and autoimmune haemolytic anemia: a case report and review of the literature. Hippokratia.
Vlachaki Efthymia, Mainou M, Bekiari Eleni, Vetsiou E, Tsapas Apostolos (2013). Safety and efficacy of 4 years of deferasirox treatment for sickle cell disease patients. Hemoglobin. vol.37 no.1 p. 94-100.

2012

Bourli E, Dimitriadou M, Oikonomou Marina-Kely, Vlachaki Efthymia, Christoforidis Athanasios, Maratou E, Stanopoulos Ioannis, Argyropoulou-Pataka Paraskevi, Aivazis Viktor (2012). Restrictive pulmonary dysfunction and its predictors in young patients with β-thalassaemia major. Pediatric Pulmonology. vol. 47 no. 8 p. 801-807.
Sinakos Emmanouil, Vlachaki Efthymia, Tsapas Apostolos (2012). Safety of deferasirox in sickle cell disease patients with co-existing liver impairment. British Journal of Haematology. Vol.157 no.4 p.505–506.
Vlachaki Efthymia (2012). Absence of JAK2V617F mutation in patients with beta-thalassemia major and thrombocytosis due to splenectomy. Molecular Biology Reports. vol. 39 no. 5 p. 6101-6105.

2011

Paschos P, Vlachaki E, Pasvanti C, Sinakos E, Kalpaka A, Klonizakis P, Perifanis V (2011). Safety and efficacy of combination therapy with pegylated interferon alpha-2a and ribavirin in treating patients with chronic hepatitis C and beta-thalassaemia major: a Greek single-center experience. Acta Haematol. vol.126 no.4 p.231-233.
Vlachaki Efthymia, Papageorgiou V, Klonizakis F, Spandonidou M, Chisan S, Vetsiou E, Ioannidou E (2011). Total remission of severe immune thrombocytopenia after short term treatment with romiplostim. Hematology Reports. vol. 3 no. 3.
Vlachaki Efthymia (2011). Is deferasirox implicated in multiple organ failure in a patient with homozygous β-thalassemia?. Angiology. vol. 62 no. 4 p. 346-8.
Vlachaki Efthymia, Chatzinikolaou K, Bekiari Eleni, Klonizakis F, Tsapas Apostolos (2011). Is deferasirox implicated in multiple organ failure in a patient with homozygous β-thalassemia?. Angiology. vol.62 no.4 p.346-348.

2010

Diamantidis M. D, Ioannidou-Papagiannaki E, Kountouras J, Mandala E, Tsapournas G, Frida-Michailidou I, Klonizakis P, Zavos C, Haralambidou-Vranitsa S, Vlachaki E, Parapanisiou E, et al (2010). High prevalence of Helicobacter pylori infection in Greek patients with myelodysplastic syndromes. Acta Haematol. vol.124 no.3 p.141-149.
Dimitriadou M, Christoforidis A, Economou M, Tsatra I, Vlachaki E, Fidani L, Katzos G, Athanassiou-Metaxa M (2010). Elevated serum parathormone levels are associated with myocardial iron overload in patients with beta-thalassaemia major. Eur J Haematol. vol.84 no.1 p.64-71.

2009

Christoforidis A, Perifanis V, Spanos G, Vlachaki E, Economou M, Tsatra I, Athanassiou-Metaxa M (2009). MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations. Eur J Haematol. vol.82 no.5 p.388-392.
Christoforidis A, Perifanis V, Papadopoulou E, Dimitriadou M, Kazantzidou E, Vlachaki E, Tsatra I (2009). Poor correlations between measurements of bone quality by quantitative ultrasound sonography and dual energy X-ray absorptiometry in patients with beta-thalassaemia major. Eur J Haematol. vol.82 no.1 p.15-21.
Vlachaki Efthymia, Tsapas Apostolos, Dimitrakopoulos K, Kontzoglou G, Klonizakis Ioannis (2009). Parotid gland oncocytoma: a case report. Cases Journal. vol.2 p.6423.

2008

Christoforidis A, Vlachaki E, Perifanis V, Frida-Michaelidou I, Tsatra I (2008). Can Helicobacter pylori infection be proven beneficial to patients with beta-thalassaemia major?. Med Hypotheses. vol.71 no.4 p.616-617.
Tsapas Apostolos, Vlachaki Efthymia, Sarigianni M, Klonizakis F, Paletas Konstantinos (2008). Restoration of insulin sensitivity following treatment with imatinib mesylate (Gleevec) in non-diabetic patients with chronic myelogenic leukemia (CML). Leukemia Research. vol.32 no.4 p.674-675.
Tsapas Apostolos, Paletas Konstantinos, Vlachaki Efthymia, Bekiari Eleni, Spanos Konstantinos, Economidis D (2008). Eosinophilic pneumonia associated with heroin inhalation: a case report. Wiener klinische Wochenschrift. vol.120 no.5-6 p.178-180.
Vlachaki E, Tselios K, Charalambidou S, Ioannidou E, Klonizakis I (2008). Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report. Int J Hematol. vol.88 no.3 p.341-342.

2007

Christoforidis A, Zevgaridou E, Tsatra I, Perifanis V, Vlachaki E, Papassotiriou I, Apostolakou F, Athanassiou-Metaxa M (2007). Urinary iron excretion in young thalassemic patients receiving combined chelation treatment with deferoxamine and deferiprone. J Pediatr Hematol Oncol. vol.29 no.9 p.598-601.
Christoforidis A, Perifanis V, Tsatra I, Vlachaki E, Athanassiou-Metaxa M (2007). Evolution of OGTT in patients with beta-thalassaemia major in relation to chelation therapy. Diabetes Res Clin Pract. vol.76 no.1 p.6-11.
Christoforidis A, Lefkou E, Vlachaki E, Perifanis V, Tsatra I, Dogramatzi F, Athanassiou-Metaxa M (2007). Evaluation of serum tumour markers concentrations in patients with homozygous beta-thalassaemia in relation to demographical, clinical and biochemical parameters. Ann Hematol. vol.86 no.11 p.837-841.
Perifanis V, Christoforidis A, Vlachaki E, Tsatra I, Spanos G, Athanassiou-Metaxa M (2007). comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major. Int J Hematol. vol.86 no.5 p.385-389.
Tsapas Apostolos, Vlachaki Efthymia, Christoforidis Athanasios, Sarigianni M, Bekiari Eleni, Perifanis Vasileios, Tsapas V, Paletas Konstantinos, Athanasiou-Metaxa Miranta (2007). Insulin sensitivity assessment with euglycemic insulin clamp in adult beta-thalassaemia major patients. European Journal of Haematology. vol.79 no.6 p.526-530.
Tsapas Apostolos, Vlachaki Efthymia, Charalambidou-Vranitsa S, Kostikidis M, Bekiari Eleni, Ioannidou-Papagiannaki Elisavet, Paletas Konstantinos (2007). Hemosiderosis and diabetes mellitus in an untransfused patient with hemoglobin H disease and H63D homozygous hereditary hemochromatosis. Diabetes Research and Clinical Practice. vol.76 no.3 p.468-469.
Vlachaki E, Ioannidou-Papagiannaki E, Tziomalos K, Haralambidou-Vranitsa S, Perifanis V, Klonizakis I, Athanassiou-Metaxa M (2007). Peripheral blood haematopoietic progenitor cells in patients with beta thalassaemia major receiving desferrioxamine or deferiprone as chelation therapy. Eur J Haematol. vol.78 no.1 p.48-51.
Vlachaki Efthymia, Tselios K, Tsapas Apostolos, Klonizakis Ioannis (2007). Yersinia enterocolitica O:3 mesenteric lymphadenopathy in an apparently healthy adult. Netherland the Journal of Medicine. vol.65 no.8 p.311-312.

----

Vlachaki Efthymia, Agapidou A, Neokleous N, Adamidou D, Vetsiou E, Boura Panagiota. Thrombotic thrombocytopenic purpura or immune thrombocytopenia in a sickle cell/β+-thalassemia patient: A rare and challenging condition.
Vlachaki Efthymia, Sousos N, Perifanis Vasileios, Kaiafa Georgia, Onoufriadis I, Hatzitolios A, Boura Panagiota. Is There a Role for Low-Dose Eltrombopag as Maintenance Therapy in the Treatment of Immune Thrombocytopenia?. Acta Haematologica. Vol. 133 no. 1 p. 78-82.

Mis à jour: 2018-02-03